Skip to main content
    C

    Contineum Therapeutics, Inc. Class A Common Stock (CTNM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.55
    -0.12 (-1.24%)

    Market Cap: $379.70M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a latest price of $9.55 on Nov 17, 2026, 46.3% below its 52-week high of $17.79. Its price fell 10.4% over the past 12 months.

    Price Chart

    From Apr 2024 to Oct 2026, its highest month-end close was $20.06 in Jul 2024 and its lowest $3.66 in May 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CTNM with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CTNM.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 40.4%, and over 6 months it fell 25.2%.

    PeriodChange
    1 month+28.4%
    3 months-40.4%
    6 months-25.2%
    12 months-10.4%
    12 months, with dividends-10.4%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$9.39-17.8%
    2025$11.43-22.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 13.3% below its 50-day average of $11.01 and 28.5% below its 200-day average of $13.35.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$9.55
    52-week high$17.79-46.3%
    52-week low$6.72+42.1%
    50-day average$11.01-13.3%
    200-day average$13.35-28.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 84.4%.

    MeasureValue
    1-year beta1.64
    Largest fall, 1 year-59.7%
    Largest fall, 3 years-84.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CTNM

    What is CTNM's 1-year price change?

    Contineum Therapeutics, Inc. Class A Common Stock's price fell 10.4% over the past 12 months. With dividends included, the 12-month total return was -10.4%.

    What is CTNM's 52-week high and low?

    Contineum Therapeutics, Inc. Class A Common Stock's 52-week high is $17.79 and its 52-week low is $6.72. Its latest price of $9.55 on Nov 17, 2026 is 46.3% below the high.

    What is CTNM's beta?

    Contineum Therapeutics, Inc. Class A Common Stock's 1-year beta against the S&P 500 is 1.64, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.7%.

    Is the CTNM chart free?

    Yes. Advanced Charting for CTNM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.